<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">Hypoglycaemia</z:e> is a frequent finding during the neonatal period and may be due to insulin overproduction </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> have reduced numbers of somatostatin-producing cells and decreased extractable somatostatin </plain></SENT>
<SENT sid="2" pm="."><plain>In this study the effect of long-acting somatostatin (SMS201-995) on the <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin levels in an infant with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and hyperinsulinaemic non-<z:e sem="disease" ids="C0271713" disease_type="Disease or Syndrome" abbrv="">ketotic hypoglycaemia</z:e> is described </plain></SENT>
<SENT sid="3" pm="."><plain>SMS201-995 lowered basal insulin levels while maintaining <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin homeostasis </plain></SENT>
<SENT sid="4" pm="."><plain>During fasting however, both <z:chebi fb="105" ids="17234">glucose</z:chebi> levels declined rapidly whereas insulin levels did not </plain></SENT>
<SENT sid="5" pm="."><plain>The absence of both <z:hpo ids='HP_0001946'>ketosis</z:hpo> and elevated levels of free fatty acids and <z:chebi fb="4" ids="24996">lactate</z:chebi> during <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e>, as observed in our patient, are important diagnostic clues since the insulin levels themselves may sometimes be only slightly elevated </plain></SENT>
</text></document>